This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2006 Oct;41(10):1020-2.

doi: 10.1007/s00535-006-1897-8.

Renin-angiotensin system and progression of chronic liver diseases

Hitoshi Yoshiji, Hiroshi Fukui

PMID: 17096072
DOI: 10.1007/s00535-006-1897-8

Editorial

Renin-angiotensin system and progression of chronic liver diseases

Hitoshi Yoshiji et al. J Gastroenterol. 2006 Oct.

. 2006 Oct;41(10):1020-2.

doi: 10.1007/s00535-006-1897-8.

Authors

Hitoshi Yoshiji, Hiroshi Fukui

PMID: 17096072
DOI: 10.1007/s00535-006-1897-8

No abstract available

PubMed Disclaimer

Comment on

Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats.
Ueki M, Koda M, Yamamoto S, Matsunaga Y, Murawaki Y. Ueki M, et al. J Gastroenterol. 2006 Oct;41(10):996-1004. doi: 10.1007/s00535-006-1891-1. Epub 2006 Nov 9. J Gastroenterol. 2006. PMID: 17096069

Similar articles

Possible involvement of angiogenesis in chronic liver diseases: interaction among renin-angiotensin-aldosterone system, insulin resistance and oxidative stress.
Kaji K, Yoshiji H, Ikenaka Y, Noguchi R, Aihara Y, Shirai Y, Douhara A, Fukui H. Kaji K, et al. Curr Med Chem. 2012;19(12):1889-98. doi: 10.2174/092986712800099848. Curr Med Chem. 2012. PMID: 22376037 Review.
Pathways of hepatic and renal damage through non-classical activation of the renin-angiotensin system in chronic liver disease.
Sansoè G, Aragno M, Wong F. Sansoè G, et al. Liver Int. 2020 Jan;40(1):18-31. doi: 10.1111/liv.14272. Epub 2019 Nov 4. Liver Int. 2020. PMID: 31580514 Review.
Does the intrarenal reactive oxygen species/angiotensinogen/renin-Angiotensin system axis play an important role in the progression of chronic kidney disease?
Konishi Y, Imanishi M. Konishi Y, et al. Clin Exp Pharmacol Physiol. 2009 Aug;36(8):748-9. doi: 10.1111/j.1440-1681.2009.05218.x. Epub 2009 May 19. Clin Exp Pharmacol Physiol. 2009. PMID: 19473185 No abstract available.
The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease.
Ahmed AK, Kamath NS, El Kossi M, El Nahas AM. Ahmed AK, et al. Nephrol Dial Transplant. 2010 Dec;25(12):3977-82. doi: 10.1093/ndt/gfp511. Epub 2009 Oct 10. Nephrol Dial Transplant. 2010. PMID: 19820248
Renin-angiotensin inhibitors in stage 4 chronic kidney disease.
Hirsch S. Hirsch S. Kidney Int. 2006 Nov;70(10):1880; author reply 1880-1. doi: 10.1038/sj.ki.5001837. Kidney Int. 2006. PMID: 17080165 No abstract available.

See all similar articles

Cited by

The effect of angiotensin-blocking agents on liver fibrosis in patients with hepatitis C.
Corey KE, Shah N, Misdraji J, Abu Dayyeh BK, Zheng H, Bhan AK, Chung RT. Corey KE, et al. Liver Int. 2009 May;29(5):748-53. doi: 10.1111/j.1478-3231.2009.01973.x. Epub 2009 Feb 9. Liver Int. 2009. PMID: 19220742 Free PMC article.
Medications in type-2 diabetics and their association with liver fibrosis.
Siddiqui MT, Amin H, Garg R, Chadalavada P, Al-Yaman W, Lopez R, Singh A. Siddiqui MT, et al. World J Gastroenterol. 2020 Jun 21;26(23):3249-3259. doi: 10.3748/wjg.v26.i23.3249. World J Gastroenterol. 2020. PMID: 32684739 Free PMC article.
The renin-angiotensin system and hypertension in autosomal recessive polycystic kidney disease.
Goto M, Hoxha N, Osman R, Dell KM. Goto M, et al. Pediatr Nephrol. 2010 Dec;25(12):2449-57. doi: 10.1007/s00467-010-1621-z. Epub 2010 Aug 27. Pediatr Nephrol. 2010. PMID: 20798958
Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic Approach.
Orlandi P, Solini A, Banchi M, Brunetto MR, Cioni D, Ghiadoni L, Bocci G. Orlandi P, et al. Pharmaceuticals (Basel). 2021 Sep 29;14(10):995. doi: 10.3390/ph14100995. Pharmaceuticals (Basel). 2021. PMID: 34681219 Free PMC article. Review.
Attrition of Hepatic Damage Inflicted by Angiotensin II with α-Tocopherol and β-Carotene in Experimental Apolipoprotein E Knock-out Mice.
Gopal K, Gowtham M, Sachin S, Ravishankar Ram M, Shankar EM, Kamarul T. Gopal K, et al. Sci Rep. 2015 Dec 16;5:18300. doi: 10.1038/srep18300. Sci Rep. 2015. PMID: 26670291 Free PMC article.

References

1. Gastroenterology. 2000 Mar;118(3):565-72 - PubMed
1. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):6038-45 - PubMed
1. Gut. 2003 Sep;52(9):1347-54 - PubMed
1. Hepatol Res. 2001 Oct;21(2):147-158 - PubMed
1. Curr Cancer Drug Targets. 2004 Nov;4(7):555-67 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer
Medical
- MedlinePlus Health Information